Global Human Insulin Market Research Report 2023

Report ID: 1911477 | Published Date: Jan 2025 | No. of Page: 99 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Human Insulin Market Overview
    1.1 Product Overview and Scope of Human Insulin
    1.2 Human Insulin Segment by Type
        1.2.1 Global Human Insulin Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Insulin Analogs and Biosimilars
        1.2.3 Human Insulin Biologics
    1.3 Human Insulin Segment by Application
        1.3.1 Global Human Insulin Sales Comparison by Application: (2022-2028)
        1.3.2 Short Acting
        1.3.3 Intermediate Acting
        1.3.4 Long Acting
        1.3.5 Pre-Mix Insulin
    1.4 Global Human Insulin Market Size Estimates and Forecasts
        1.4.1 Global Human Insulin Revenue 2017-2028
        1.4.2 Global Human Insulin Sales 2017-2028
        1.4.3 Human Insulin Market Size by Region: 2017 Versus 2021 Versus 2028
2 Human Insulin Market Competition by Manufacturers
    2.1 Global Human Insulin Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Human Insulin Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Human Insulin Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Human Insulin Manufacturing Sites, Area Served, Product Type
    2.5 Human Insulin Market Competitive Situation and Trends
        2.5.1 Human Insulin Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Human Insulin Players Market Share by Revenue
        2.5.3 Global Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Insulin Retrospective Market Scenario by Region
    3.1 Global Human Insulin Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Human Insulin Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Human Insulin Market Facts & Figures by Country
        3.3.1 North America Human Insulin Sales by Country
        3.3.2 North America Human Insulin Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Human Insulin Market Facts & Figures by Country
        3.4.1 Europe Human Insulin Sales by Country
        3.4.2 Europe Human Insulin Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Human Insulin Market Facts & Figures by Region
        3.5.1 Asia Pacific Human Insulin Sales by Region
        3.5.2 Asia Pacific Human Insulin Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Human Insulin Market Facts & Figures by Country
        3.6.1 Latin America Human Insulin Sales by Country
        3.6.2 Latin America Human Insulin Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Human Insulin Market Facts & Figures by Country
        3.7.1 Middle East and Africa Human Insulin Sales by Country
        3.7.2 Middle East and Africa Human Insulin Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Human Insulin Historic Market Analysis by Type
    4.1 Global Human Insulin Sales Market Share by Type (2017-2022)
    4.2 Global Human Insulin Revenue Market Share by Type (2017-2022)
    4.3 Global Human Insulin Price by Type (2017-2022)
5 Global Human Insulin Historic Market Analysis by Application
    5.1 Global Human Insulin Sales Market Share by Application (2017-2022)
    5.2 Global Human Insulin Revenue Market Share by Application (2017-2022)
    5.3 Global Human Insulin Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 B. Braun
        6.1.1 B. Braun Corporation Information
        6.1.2 B. Braun Description and Business Overview
        6.1.3 B. Braun Human Insulin Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 B. Braun Human Insulin Product Portfolio
        6.1.5 B. Braun Recent Developments/Updates
    6.2 Becton, Dickinson
        6.2.1 Becton, Dickinson Corporation Information
        6.2.2 Becton, Dickinson Description and Business Overview
        6.2.3 Becton, Dickinson Human Insulin Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Becton, Dickinson Human Insulin Product Portfolio
        6.2.5 Becton, Dickinson Recent Developments/Updates
    6.3 Biocon
        6.3.1 Biocon Corporation Information
        6.3.2 Biocon Description and Business Overview
        6.3.3 Biocon Human Insulin Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Biocon Human Insulin Product Portfolio
        6.3.5 Biocon Recent Developments/Updates
    6.4 Biodel
        6.4.1 Biodel Corporation Information
        6.4.2 Biodel Description and Business Overview
        6.4.3 Biodel Human Insulin Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Biodel Human Insulin Product Portfolio
        6.4.5 Biodel Recent Developments/Updates
    6.5 ELI Lilly
        6.5.1 ELI Lilly Corporation Information
        6.5.2 ELI Lilly Description and Business Overview
        6.5.3 ELI Lilly Human Insulin Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 ELI Lilly Human Insulin Product Portfolio
        6.5.5 ELI Lilly Recent Developments/Updates
    6.6 Julphar
        6.6.1 Julphar Corporation Information
        6.6.2 Julphar Description and Business Overview
        6.6.3 Julphar Human Insulin Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Julphar Human Insulin Product Portfolio
        6.6.5 Julphar Recent Developments/Updates
    6.7 NOVO Nordisk
        6.6.1 NOVO Nordisk Corporation Information
        6.6.2 NOVO Nordisk Description and Business Overview
        6.6.3 NOVO Nordisk Human Insulin Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 NOVO Nordisk Human Insulin Product Portfolio
        6.7.5 NOVO Nordisk Recent Developments/Updates
    6.8 Sanofi
        6.8.1 Sanofi Corporation Information
        6.8.2 Sanofi Description and Business Overview
        6.8.3 Sanofi Human Insulin Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Sanofi Human Insulin Product Portfolio
        6.8.5 Sanofi Recent Developments/Updates
    6.9 Wockhardt
        6.9.1 Wockhardt Corporation Information
        6.9.2 Wockhardt Description and Business Overview
        6.9.3 Wockhardt Human Insulin Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Wockhardt Human Insulin Product Portfolio
        6.9.5 Wockhardt Recent Developments/Updates
    6.10 Ypsomed
        6.10.1 Ypsomed Corporation Information
        6.10.2 Ypsomed Description and Business Overview
        6.10.3 Ypsomed Human Insulin Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Ypsomed Human Insulin Product Portfolio
        6.10.5 Ypsomed Recent Developments/Updates
7 Human Insulin Manufacturing Cost Analysis
    7.1 Human Insulin Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Human Insulin
    7.4 Human Insulin Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Human Insulin Distributors List
    8.3 Human Insulin Customers
9 Human Insulin Market Dynamics
    9.1 Human Insulin Industry Trends
    9.2 Human Insulin Market Drivers
    9.3 Human Insulin Market Challenges
    9.4 Human Insulin Market Restraints
10 Global Market Forecast
    10.1 Human Insulin Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Human Insulin by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Human Insulin by Type (2023-2028)
    10.2 Human Insulin Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Human Insulin by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Human Insulin by Application (2023-2028)
    10.3 Human Insulin Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Human Insulin by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Human Insulin by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Human Insulin Sales Growth Rate Comparison by Type (2022-2028) & (K Doses) & (US$ Million)
    Table 2. Global Human Insulin Sales Growth Rate Comparison by Application (2022-2028) & (K Doses) & (US$ Million)
    Table 3. Global Human Insulin Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Human Insulin Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Human Insulin Sales (K Doses) of Key Manufacturers (2017-2022)
    Table 6. Global Human Insulin Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Human Insulin Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Human Insulin Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Human Insulin Average Price (USD/Dose) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Human Insulin Manufacturing Sites and Area Served
    Table 11. Manufacturers Human Insulin Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Human Insulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Insulin as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Human Insulin Sales by Region (2017-2022) & (K Doses)
    Table 16. Global Human Insulin Sales Market Share by Region (2017-2022)
    Table 17. Global Human Insulin Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Human Insulin Revenue Market Share by Region (2017-2022)
    Table 19. North America Human Insulin Sales by Country (2017-2022) & (K Doses)
    Table 20. North America Human Insulin Sales Market Share by Country (2017-2022)
    Table 21. North America Human Insulin Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Human Insulin Revenue Market Share by Country (2017-2022)
    Table 23. Europe Human Insulin Sales by Country (2017-2022) & (K Doses)
    Table 24. Europe Human Insulin Sales Market Share by Country (2017-2022)
    Table 25. Europe Human Insulin Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Human Insulin Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Human Insulin Sales by Region (2017-2022) & (K Doses)
    Table 28. Asia Pacific Human Insulin Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Human Insulin Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Human Insulin Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Human Insulin Sales by Country (2017-2022) & (K Doses)
    Table 32. Latin America Human Insulin Sales Market Share by Country (2017-2022)
    Table 33. Latin America Human Insulin Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Human Insulin Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Human Insulin Sales by Country (2017-2022) & (K Doses)
    Table 36. Middle East and Africa Human Insulin Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Human Insulin Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Human Insulin Revenue Market Share by Country (2017-2022)
    Table 39. Global Human Insulin Sales by Type (2017-2022) & (K Doses)
    Table 40. Global Human Insulin Sales Market Share by Type (2017-2022)
    Table 41. Global Human Insulin Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Human Insulin Revenue Share by Type (2017-2022)
    Table 43. Global Human Insulin Price by Type (2017-2022) & (USD/Dose)
    Table 44. Global Human Insulin Sales (K Doses) by Application (2017-2022)
    Table 45. Global Human Insulin Sales Market Share by Application (2017-2022)
    Table 46. Global Human Insulin Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Human Insulin Revenue Share by Application (2017-2022)
    Table 48. Global Human Insulin Price by Application (2017-2022) & (USD/Dose)
    Table 49. B. Braun Corporation Information
    Table 50. B. Braun Description and Business Overview
    Table 51. B. Braun Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 52. B. Braun Human Insulin Product
    Table 53. B. Braun Recent Developments/Updates
    Table 54. Becton, Dickinson Corporation Information
    Table 55. Becton, Dickinson Description and Business Overview
    Table 56. Becton, Dickinson Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 57. Becton, Dickinson Human Insulin Product
    Table 58. Becton, Dickinson Recent Developments/Updates
    Table 59. Biocon Corporation Information
    Table 60. Biocon Description and Business Overview
    Table 61. Biocon Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 62. Biocon Human Insulin Product
    Table 63. Biocon Recent Developments/Updates
    Table 64. Biodel Corporation Information
    Table 65. Biodel Description and Business Overview
    Table 66. Biodel Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 67. Biodel Human Insulin Product
    Table 68. Biodel Recent Developments/Updates
    Table 69. ELI Lilly Corporation Information
    Table 70. ELI Lilly Description and Business Overview
    Table 71. ELI Lilly Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 72. ELI Lilly Human Insulin Product
    Table 73. ELI Lilly Recent Developments/Updates
    Table 74. Julphar Corporation Information
    Table 75. Julphar Description and Business Overview
    Table 76. Julphar Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 77. Julphar Human Insulin Product
    Table 78. Julphar Recent Developments/Updates
    Table 79. NOVO Nordisk Corporation Information
    Table 80. NOVO Nordisk Description and Business Overview
    Table 81. NOVO Nordisk Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 82. NOVO Nordisk Human Insulin Product
    Table 83. NOVO Nordisk Recent Developments/Updates
    Table 84. Sanofi Corporation Information
    Table 85. Sanofi Description and Business Overview
    Table 86. Sanofi Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 87. Sanofi Human Insulin Product
    Table 88. Sanofi Recent Developments/Updates
    Table 89. Wockhardt Corporation Information
    Table 90. Wockhardt Description and Business Overview
    Table 91. Wockhardt Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 92. Wockhardt Human Insulin Product
    Table 93. Wockhardt Recent Developments/Updates
    Table 94. Ypsomed Corporation Information
    Table 95. Ypsomed Description and Business Overview
    Table 96. Ypsomed Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 97. Ypsomed Human Insulin Product
    Table 98. Ypsomed Recent Developments/Updates
    Table 99. Production Base and Market Concentration Rate of Raw Material
    Table 100. Key Suppliers of Raw Materials
    Table 101. Human Insulin Distributors List
    Table 102. Human Insulin Customers List
    Table 103. Human Insulin Market Trends
    Table 104. Human Insulin Market Drivers
    Table 105. Human Insulin Market Challenges
    Table 106. Human Insulin Market Restraints
    Table 107. Global Human Insulin Sales Forecast by Type (2023-2028) & (K Doses)
    Table 108. Global Human Insulin Sales Market Share Forecast by Type (2023-2028)
    Table 109. Global Human Insulin Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 110. Global Human Insulin Revenue Market Share Forecast by Type (2023-2028)
    Table 111. Global Human Insulin Sales Forecast by Application (2023-2028) & (K Doses)
    Table 112. Global Human Insulin Sales Market Share Forecast by Application (2023-2028)
    Table 113. Global Human Insulin Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 114. Global Human Insulin Revenue Market Share Forecast by Application (2023-2028)
    Table 115. Global Human Insulin Sales Forecast by Region (2023-2028) & (K Doses)
    Table 116. Global Human Insulin Sales Market Share Forecast by Region (2023-2028)
    Table 117. Global Human Insulin Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 118. Global Human Insulin Revenue Market Share Forecast by Region (2023-2028)
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Human Insulin
    Figure 2. Global Human Insulin Market Share by Type in 2021 & 2028
    Figure 3. Insulin Analogs and Biosimilars Product Picture
    Figure 4. Human Insulin Biologics Product Picture
    Figure 5. Global Human Insulin Market Share by Application in 2021 & 2028
    Figure 6. Short Acting
    Figure 7. Intermediate Acting
    Figure 8. Long Acting
    Figure 9. Pre-Mix Insulin
    Figure 10. Global Human Insulin Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Human Insulin Market Size (2017-2028) & (US$ Million)
    Figure 12. Global Human Insulin Sales (2017-2028) & (K Doses)
    Figure 13. Human Insulin Sales Share by Manufacturers in 2021
    Figure 14. Global Human Insulin Revenue Share by Manufacturers in 2021
    Figure 15. The Global 5 and 10 Largest Human Insulin Players: Market Share by Revenue in 2021
    Figure 16. Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 17. Global Human Insulin Sales Market Share by Region (2017-2022)
    Figure 18. Global Human Insulin Sales Market Share by Region in 2021
    Figure 19. Global Human Insulin Revenue Market Share by Region (2017-2022)
    Figure 20. Global Human Insulin Revenue Market Share by Region in 2021
    Figure 21. U.S. Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Canada Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Germany Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. France Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. U.K. Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Italy Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Russia Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. China Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Japan Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. South Korea Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. India Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Australia Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Taiwan Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Indonesia Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Thailand Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Malaysia Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Philippines Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Vietnam Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Mexico Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Brazil Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Argentina Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Turkey Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Saudi Arabia Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. UAE Human Insulin Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Sales Market Share of Human Insulin by Type (2017-2022)
    Figure 46. Manufacturing Cost Structure of Human Insulin
    Figure 47. Manufacturing Process Analysis of Human Insulin
    Figure 48. Human Insulin Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
B. Braun
Becton, Dickinson
Biocon
Biodel
ELI Lilly
Julphar
NOVO Nordisk
Sanofi
Wockhardt
Ypsomed
Frequently Asked Questions
Human Insulin report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Insulin report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Insulin report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Humectants

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More